Teva and Barr Receive FTC Request for Additional Information
JERUSALEM and MONTVALE, N.J., Sept. 3 /PRNewswire-FirstCall/ -- Teva
Pharmaceutical Industries Ltd. (Nasdaq: TEVA ) and Barr
Inc. (NYSE: BRL ) announced today that, as expected, each party has received
a request for additional information (commonly referred to as a "second
Wendel Barr Appointed Chief Operating Officer of Covance
- Mike Lehmann Named President, Labs North America -
PRINCETON, N.J., Dec. 18 /PRNewswire-FirstCall/ -- Covance Inc. (NYSE:
CVD) today announced that Wendel Barr
has been named Covance's Chief
Operating Officer, effective January 1, 2008. Mr. Barr, who is currently
President of Early...
Watson Confirms Patent Litigation With Barr Related to Seasonale(R)
CORONA, Calif., Dec. 14 /PRNewswire-FirstCall/ -- Watson
Pharmaceuticals, Inc. (NYSE: WPI ), a leading specialty pharmaceutical
company, confirmed today that Duramed Pharmaceuticals, Inc., a wholly owned
subsidiary of Barr
Pharmaceuticals, Inc., has filed a patent lawsuit
against Watson and c...
Watson Enters Into Agreement to Acquire Products Related to Teva's Proposed Acquisition of Barr
CORONA, Calif., Nov. 25 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals,
Inc. (NYSE: WPI ), a leading specialty pharmaceutical company, today announced
a definitive agreement to acquire a portfolio of generic pharmaceutical
products that are being divested as a result of the proposed merger bet...
Epstein - Barr virus Protein Implicated in Blood Cancer
Researchers at the University Of Pennsylvania School Of Medicine had identified a link between an Epstein - Barr
virus (EBV) protein and a vital cancer pathway earlier this year//. They have now proceeded further in this research and have found that the viral protein, named EBNA3C is responsible fo...
Perrigo Announces FDA Approval for Generic Version of NASACORT(R) AQ
...rstCall/ -- Perrigo Company (Nasdaq: PRGO ; TASE) today announced that its partner Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA ) (previously barr
Laboratories Inc.) has received final approval from the U.S. Food and Drug Administration to market Triamcinolone Acetonide Nasal Spray containing a p...
Mylan Announces Enhancements to Executive Management Team
...president, Global Generic Sales and Marketing, for barr
Laboratories, whose parent company, barr
Pharmaceuticals, was acquired by Teva. In that pos...s vice president, Generic Sales and Marketing, for barr
Laboratories. In that role, he led the company's e...
Watson Pharmaceuticals Reports Second Quarter 2009 GAAP EPS of $0.46; Adjusted EPS $0.61; Company Raises 2009 Outlook
...ther revenue decreased $25.0 million to $7.4 million. Generic other revenue for the second quarter 2008 included a $15.0 million sales milestone from barr
Pharmaceuticals, Inc. following a 1999 legal settlement.
Adjusted Generic gross profit was $175.2 million in the second quarter of 2009, compar...
Cardinal Health Appoints Bruce Downey to Board of Directors; John McCoy Retires From Board After 22 Years
...board for personal reasons after 22 years of service to the company as a director.
Downey is the former chairman and chief executive officer of barr
Pharmaceuticals, Inc. and past chairman of the Generic Pharmaceutical Association.
"John McCoy has been a committed board member for more than t...
Boost Natural Killer Cells to Prevent Swine Flu
...drome, fibromyalgia, Lymes Disease, Babesia, or HIV are more likely to have lower Natural Killer Cell levels. Herpes Simplex, Human Herpes 6, Epstein barr
and Cytomegalus viruses also suppress immunity.
Dr. Sponaugle also recommends reducing sugar consumption, to increase immunity. Studies reveal c...
BioTech Firm Decodes Current Swine Flu BioMarkers
...ful results that enhance and support the body's innate ability to protect itself efficiently from pathogens and viruses such as Herpes and the Epstein barr
Virus. The process of Sound Presentation consists of monitoring biofeedback responses while playing specially selected combinations of low frequency ...
Private-label OTC Drugs Post Solid Gains in 2008, According to Kline
...s was the other area that grew 7.3% in 2008 as a result of strong sales growth of personal lubricants, as well as the Rx-to-OTC switch brand Plan B by barr
"By contrasting the overall growth rates for OTCs with the growth rates for private-label products we can easily make the case tha...
Preventing Shaken Baby Syndrome
...blic health work because the results show it's possible to change people's ideas about crying," said Dr. Ronald Barr, the lead author of both studies. barr
is director of community child health at the Child & Family Research Institute and a professor of pediatrics at the University of British Columbia...
Educational materials increase knowledge and behaviors important for preventing shaken baby syndrome
... Ronald Barr, the lead author of both studies. Dr. barr
is head of community child health at the Child & F...edicine at the University of British Columbia. Dr. barr
is a Canada Research Chair in Community Child Heal...ers about the dangers of shaking an infant.
and Ms. Marilyn Barr, Executive Director of the Na...
Warner Chilcott Reports Operating Results for the Quarter and Year Ended December 31, 2008
...uarter, a decrease of $2.7 million.
In December 2008, the Company entered into a settlement and license agreement with barr
Pharmaceuticals, Inc., which was subsequently acquired by Teva Pharmaceutical Industries, Ltd., to resolve the pending patent litigation relating to F...
Sanofi-aventis Delivers 2008 Results Above Guidance
...XRP6258 in breast cancer (EUR 1,175 million) and the settlement agreed with barr
relating to Nasacort(R) in November 2008. This adjustment has no cash impac...nd XRP6258 in breast cancer (EUR 1,175 million), the settlement agreed with barr
relating to Nasacort(R) in November 2008, and the discontinuation of ilepat...
Perrigo Reports Record Second Quarter Sales
litigation brought by Sanofi-Aventis against barr
Laboratories, Inc. (Barr), a
subsidiary of barr
Pharmaceuticals, Inc. The suit was brought in the ...ng a paragraph IV
certification for NASACORT(R)AQ. barr
developed its Triamcinolone Acetonide
Nasal Spray ...
Warner Chilcott and Watson Pharmaceuticals Announce Agreements on Loestrin(R) 24 and Femcon(R) Fe Patent Litigation
... market. The agreement covering Femcon(R) Fe
will permit Watson to commence marketing its generic equivalent product on the
earlier of 180 days after barr
Laboratories, Inc. (now Teva Pharmaceutical
Industries, Ltd.) enters the market with a generic equivalent product, or
January 1, 2013. The parties wi...
Barr's BLA for Adenovirus Type 4 and 7 Live Oral Vaccines Accepted for Filing by FDA
... MONTVALE, N.J., Dec. 11 /PRNewswire-FirstCall/ -- barr
Pharmaceuticals, Inc. (NYSE: BRL ) today announc....
Barr/DOD Project Summary
In 2001, barr
entered into a multi-year agreement with the U.S. ... Vaccines, Type 4 and 7. As part of the agreement, barr
constructed a dedicated facility to support the pr...
FDA Approves Duramed's Synthetic Conjugated Estrogens-A Vaginal Cream
... MONTVALE, N.J., Dec. 1 /PRNewswire-FirstCall/ -- barr
Pharmaceuticals, Inc. (NYSE: BRL ) today announc...d risks for the individual woman.
Pharmaceuticals, Inc. is a global specialty pharma...
Barr Confirms Patent Challenge of Amrix(R) Extended-Release Capsules, 15mg & 30mg
... MONTVALE, N.J., Nov. 26 /PRNewswire/ -- barr
Pharmaceuticals, Inc. (NYSE: BRL ) today confirmed that its subsidiary, barr
Laboratories, Inc., has initiated a challenge of t...extended-release capsules, 15mg and 30mg.
filed its Abbreviated New Drug Application (ANDA) ...
Barr Shareholders Approve Pending Teva Acquisition
... MONTVALE, N.J., Nov. 21 /PRNewswire-FirstCall/ -- barr
Pharmaceuticals, Inc. (NYSE: BRL ) today announc...s submitted to them relating to the acquisition of barr
by Teva Pharmaceuticals Industries Ltd. (Nasdaq: ...the overwhelming support of the transaction by the barr
shareholders," said Bruce L. Downey, Barr's Chairm...
Perrigo Acknowledges Settlement of NASACORT(R) AQ Nasal Spray Patent Litigation
brought by Sanofi-Aventis (NYSE: SNY ) against barr
Laboratories, Inc. a
subsidiary of barr
Pharmaceuticals, Inc. (NYSE: BRL ). The suit wa...al Spray containing a paragraph IV
believes that it is the first to file an Abbreviat...
Barr Announces Agreements on Nasacort(R) AQ, Allegra(R) D-12 and Allegra(R) Patent Challenges
...MONTVALE, N.J., Nov. 19 /PRNewswire-FirstCall/ -- barr
Pharmaceuticals, Inc. (NYSE: BRL ) today announced that its subsidiary, barr
Laboratories, Inc. has entered into separate settl...bout the possible impact of ongoing litigation for barr
and Teva related to the launch of generic versions...
Barr Announces Approval of Generic Camptosar(R) Injection, 20 mg/mL
... MONTVALE, N.J., Nov. 3 /PRNewswire-FirstCall/ -- barr
Inc. (NYSE: BRL ) today announce...nded August 2008, based on IMS sales data.
Pharmaceuticals, Inc. is a global specialty pharma...
World Anticoagulants Market to Exceed $12 Billion by 2015, According to New Report by Global Industry Analysts, Inc.
...h US$38.3 million. In Europe, France represents the largest market with a 23.8% share.
Major market participants profiled include AstraZeneca PLC, barr
Laboratories Inc., Bristol-Myers Squibb Company, Celgene Corporation, GlaxoSmithKline plc, Mitsubishi Tanabe Pharma Corporation, Pfizer Inc., and Sano...
Barr Announces Agreements to Settle Mirapex(R) and Aggrenox(R) Patent Challenges
... MONTVALE, N.J., Aug. 12 /PRNewswire-FirstCall/ -- barr
Inc. (NYSE: BRL ) announced today that its barr
Laboratories subsidiary has
signed a Settlement Ag...ringer Ingelheim's
Mirapex(R) product. Separately, barr
Laboratories entered into a Settlement
Barr Confirms Patent Challenge of Xyzal(R), 5mg Tablets
... MONTVALE, N.J., July 31 /PRNewswire-FirstCall/ -- barr
Inc. (NYSE: BRL ) today confirmed that its subsidiaries, barr
Inc. and PLIVA-Hrvatska D.O.O., have...r the
twelve month period ending May 2008.
Grant will help patients with schizophrenia who smoke
... Dr Ruth Barr, a psychiatrist in the School of Medicine and Dentistry.
hopes to build on research she has carried out during a fellowship at Harva...nd 40 volunteers, including both those with and without the condition.
said: "The reasons behind the increased need to smoke in patients with schi...
Barr Will Host an Earnings Conference Call on August 7, 2008 to Discuss the Results for the Second Quarter of Calendar 2008
... MONTVALE, N.J., July 3 /PRNewswire-FirstCall/ -- barr
Inc. (NYSE: BRL ) today announce...d or install any necessary audio software.
Pharmaceuticals, Inc. is a global specialty pharma...
Barr and Bayer Sign Supply and Licensing Agreements for Launch of Generic Yasmin(R) and Yaz(R) Oral Contraceptives
... - barr
Plans to Launch Generic Yasmin(R) on or before July 1, 2008 - barr
Plans to Launch Generic Yaz(R) on or before July 1... MONTVALE, N.J., June 24 /PRNewswire-FirstCall/ -- barr
Inc. (NYSE: BRL ) today announce...
AGA Medical Announces Management Transition
...nt of North American
Operations and a member of the Board of Directors for Haemonetics
Corporation and in a variety of roles at Baxter Healthcare. Mr. barr
B.S. in Bioengineering from the University of Pennsylvania and an MBA from
the Kellogg School of Management at Northwestern University.
Consumers, Businesses, Unions, and Medical Professionals: Time for Congress to Act on E-Prescribing Legislation
Prescription Drug Stakeholders
Pharmaceutical Care Management Association (PCMA)
BlueCross BlueShield Association
Coalition for a Competitive Pharmaceutical Market
Stronger-Than-Ever Generic Threat Forces Big Pharma to Be Creative
... are seeing the benefit of incorporating a generic
Generic drug makers are also becoming more aggressive, challenging
brand patents. TEVA and barr
have been instrumental in pushing to introduce
generic versions of brand name drugs long before U.S. patents expire.
Kalorama Information's report W...
Leading experts investigate Shaken Baby Syndrome
Guest Editors Robert M. Reece, Desmond K. Runyan, and Ronald G. barr
and an international group of authors significantly contribute to the incre...erived from prospective active surveillance studies, and Runyan, Berger and barr
provide an integrative proposal for the ideal system to measure inflicted n...
Barr Will Host An Earnings Conference Call on May 8, 2008 to Discuss the Results for the First Quarter of Calendar 2008
...d or install any necessary audio software.
Pharmaceuticals, Inc. is a global specialty pharma...ive pharmaceutical ingredients.
A holding company, barr
operates through its principal subsidiaries: Barr
Barr Announces Reorganization of Senior Management, Business Functions
...ur, Esq. has been named Chief Executive Officer of barr
Inc., the Company's generic pharmace... been named
President and Chief Operating Officer, barr
Laboratories, Inc., reporting
to Mundkur; and, Tim...ice President,
Global Generic Sales and Marketing, barr
Laboratories, Inc. reporting to
Mundkur. In additi...
Barr Pharmaceuticals, Inc. Executive Bios
... Chief Executive Officer, barr
-- In this newly created posi...nd sales and marketing. Under her leadership, barr
Laboratories will continue to support the prop... Operations. -- Barr: 15 years * Joined barr
In 1993 As An Associate Counsel. * Named Dir...
Barr's PLIVA Subsidiary to Terminate GDR Deposit Agreement and Delist From London Stock Exchange
...rman and CEO.
In addition, Downey confirmed that barr
does not anticipate initiating
a squeeze-out of re...pleting the
integration of PLIVA's operations into barr
and focusing on business growth
in key world markets."
On October 24, 2006, barr
finalized the legal and regulatory
UNC, Duke lead first statewide shaken baby prevention research project in US
... National Center on Shaken Baby Syndrome. Both Dr. barr
and Marilyn barr
are collaborating with the North Carolina project.
created the concept of The Period of PURPLE Crying...